Cargando…
Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
Abnormal expression of β-catenin contributes to tumor development, progression, and metastasis in various cancers. However, little is known about the relationship between abnormal expression of β-catenin and cisplatin chemotherapy in oral squamous cell carcinoma (OSCC). The present study aimed to in...
Autores principales: | Li, Long, Liu, Hai-Chao, Wang, Cheng, Liu, Xiqiang, Hu, Feng-Chun, Xie, Nan, Lü, Lanhai, Chen, Xiaohua, Huang, Hong-Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978817/ https://www.ncbi.nlm.nih.gov/pubmed/27529071 http://dx.doi.org/10.1155/2016/5378567 |
Ejemplares similares
-
Immunohistochemical Expression of E-Cadherin and β-Catenin in Oral Squamous Cell Carcinoma
por: Akinyamoju, Akindayo Olufunto, et al.
Publicado: (2023) -
Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma
por: Liu, Haichao, et al.
Publicado: (2018) -
Involvement of RUVBL1 in WNT/β-Catenin Signaling in Oral Squamous Cell Carcinoma
por: Zeng, Yongfa, et al.
Publicado: (2022) -
Expression of E-cadherin, α-catenin, and β-catenin in the process of lymph node metastasis in oral squamous cell carcinoma
por: Tanaka, N, et al.
Publicado: (2003) -
Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Luo, Sheng-Dean, et al.
Publicado: (2015)